Cordyceps for Immune Function and Inflammation
Cordyceps carries a paradoxical reputation: it is sold both as an immune booster and as an anti-inflammatory — claims that sound contradictory until you separate the two active chemistries. The fungus's beta-glucan polysaccharides activate innate immune cells (macrophages, natural killer cells), while its small-molecule cordycepin suppresses NF-κB-driven inflammation. So Cordyceps can plausibly do both, in different contexts. Three small human trials have measured shifts in immune markers, and the anti-inflammatory mechanism of cordycepin is well documented in cells. But "immunomodulation" is a slippery word, most of the data are preclinical, and altering an immune marker in a lab is not the same as preventing illness. This page separates the mechanism from the marketing — and notes who the research raises concerns for.
Table of Contents
- The Booster-and-Calmer Paradox
- Beta-Glucans and Polysaccharides
- Macrophage and Natural Killer Cell Activation
- The Three Human Immune Trials
- Cordycepin's Anti-Inflammatory Mechanism
- What "Immunomodulation" Really Means
- Inflammatory Conditions Studied
- Autoimmune Disease and Immunosuppressants
- Practical Use
- Cautions
- Key Research Papers
- Connections
- Featured Videos
The Booster-and-Calmer Paradox
The first thing to resolve about Cordyceps and immunity is the apparent contradiction in its marketing. How can one fungus "boost" the immune system and "reduce inflammation" at the same time — when inflammation is the immune system at work? The answer is that Cordyceps contains at least two distinct classes of active compounds pulling in different directions:
- Large polysaccharides (beta-glucans) stimulate innate immune cells to be more active — the "boosting" arm.
- The small nucleoside cordycepin suppresses NF-κB and downstream inflammatory cytokines — the "calming" arm.
This is why Cordyceps is better described as an immunomodulator than a simple booster: depending on the compound, the dose, and the state of the immune system, it can push activity up or dampen excess inflammation. That flexibility is genuinely interesting biology — and also exactly why sweeping "boosts your immunity" claims oversimplify what is actually happening.
Beta-Glucans and Polysaccharides
Like most medicinal mushrooms, Cordyceps is rich in beta-glucans and other complex polysaccharides in its cell walls. These molecules are the best-studied immune-active fraction across the whole mushroom kingdom. The human immune system evolved to recognize fungal beta-glucans as a danger signal through pattern-recognition receptors — principally Dectin-1 and the Toll-like receptors (TLR-2/4) — on innate immune cells. When a beta-glucan binds these receptors, it triggers a cascade that activates the cell and releases signaling cytokines.
Reviews of Cordyceps polysaccharides (Molecules, 2024; Front Pharmacol, 2020) catalog a consistent set of effects: activation of macrophages, enhancement of natural killer cell activity, and modulation of cytokine production. Importantly, the specific structure of the polysaccharide — its sugar composition and branching — determines its activity, which is one more reason different Cordyceps products behave differently and why standardized beta-glucan content on a label is meaningful information.
Macrophage and Natural Killer Cell Activation
The clearest preclinical immune signal is the activation of the innate immune system:
- Macrophages — Cordyceps polysaccharides reliably activate cultured macrophages (the RAW 264.7 line is the standard model), increasing their production of nitric oxide and cytokines and enhancing their pathogen-engulfing capacity. A 2024 study detailed this for a C. militaris polysaccharide.
- Natural killer (NK) cells — natural killer cells are the innate system's first responders against virus-infected and tumor cells. Cordyceps extracts enhance natural killer activity in animal and cell studies, a finding echoed in the human cell-mediated-immunity trial described below.
- Dendritic cells — the bridge to adaptive immunity; Cordyceps components can promote their maturation.
These are real, reproducible laboratory effects. The honest caveat is that "my macrophages are more active in a dish" does not automatically translate to "I get fewer colds." Innate activation is a plausible mechanism for benefit; clinical proof of fewer or milder infections in healthy people is not established.
The Three Human Immune Trials
Cordyceps has more human immune data than most mushrooms — though "more" still means a small handful of small trials:
- Jung et al. (2019) — a randomized, double-blind trial of a Paecilomyces hepiali mycelium extract in healthy adults (39 given 1.68 g/day in capsules, 40 given placebo, for 8 weeks) reported a 38.8 ± 17.6% rise in natural killer cell activity from baseline compared with the placebo group.
- Kang et al. (2015) — a trial in healthy Korean men found that Cordyceps militaris supplementation enhanced markers of cell-mediated immunity, such as natural killer cell activity and certain T-cell responses. The 39 men given 1.5 g/day of ethanol-treated C. militaris in capsules for 4 weeks (40 men took placebo) showed greater rises than the placebo group in natural killer cell activity (P = .0010), lymphocyte (white blood cell) proliferation (P ≤ .0001), and the immune signalling proteins interleukin-2 (IL-2) and interferon-gamma (IFN-γ), with “no statistically significant adverse reaction.”
- Ontawong et al. (2024) — a randomized, placebo-controlled trial gave healthy men and women a fermented C. militaris drink containing 2.85 mg of cordycepin, or a placebo, for 8 weeks (n = 10 for each gender). Natural killer cell activity rose from baseline in the men at 4 weeks (p = 0.049), and in the women natural killer activity rose significantly compared with placebo after 8 weeks (p = 0.023). Blood sugar, blood fats (lipids) and the liver, kidney and blood safety measures did not differ between the groups.
How to weigh these: they are genuine randomized human trials showing that Cordyceps can shift measurable immune parameters — a meaningful step above pure cell-culture data. But all three are small, all measured surrogate immune markers rather than clinical endpoints like infection rate or illness duration, and none has been replicated at scale. They justify calling Cordyceps a plausible immunomodulator in humans; they do not justify claiming it prevents or treats any specific illness.
Cordycepin's Anti-Inflammatory Mechanism
The "calming" arm of Cordyceps is carried largely by cordycepin, and its mechanism is well characterized. In lipopolysaccharide-stimulated macrophages — the standard model of acute inflammation — cordycepin suppresses NF-κB, the master transcription factor that switches on inflammatory genes. A landmark 2006 study (Kim et al., Eur J Pharmacol) showed cordycepin inhibiting lipopolysaccharide-induced inflammation through NF-κB suppression, and subsequent work in RAW 264.7 macrophages (2014) confirmed reduced production of pro-inflammatory mediators such as nitric oxide, tumor necrosis factor-α, interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). A 2020 review in Phytotherapy Research summarizes the anti-inflammatory literature.
By quieting NF-κB, cordycepin down-regulates the same inflammatory pathway targeted by mainstream anti-inflammatory drugs. This mechanism underlies Cordyceps's effects in the airway-inflammation models and links to its RNA-modulating action — cordycepin's interference with messenger-RNA processing helps explain why it can suppress the production of inflammatory proteins. The evidence base here is strong at the cell and animal level; controlled human anti-inflammatory outcome data are still limited.
What "Immunomodulation" Really Means
"Immunomodulation" is one of the most overused words in the supplement aisle, so it is worth stating plainly what the evidence does and does not support:
- Supported: Cordyceps can change measurable immune activity — up (innate activation) or down (NF-κB inflammation) — in cells, animals, and, for a couple of markers, humans.
- Not supported: the idea that Cordyceps "balances" or "optimizes" the immune system to a healthy set-point. That is an appealing metaphor, not a demonstrated pharmacological property. Nothing about the data guarantees the changes are always in a beneficial direction for a given person.
The practical consequence is important: because Cordyceps can increase immune activity, it is not automatically safe for everyone, and "stimulating immunity" is precisely the wrong goal in some conditions (see the autoimmune caution below).
Inflammatory Conditions Studied
Because of its dual immune chemistry, Cordyceps and cordycepin have been explored in a range of inflammatory and immune contexts — almost all preclinically:
- Allergic airway inflammation (asthma models) — covered in depth on the Respiratory Support page.
- Metabolic inflammation — cordycepin reduced inflammation in fatty-liver and high-fat-diet models via AMP-activated protein kinase (AMPK) and NF-κB.
- Cancer immunology — cordycepin's antiproliferative and immune effects are an active oncology research area (reviewed 2018, 2020), though this is laboratory science, not a treatment recommendation. In people, a 2024 meta-analysis of 12 randomized trials with 928 patients tested Cordyceps sinensis as an add-on to conventional lung-cancer treatment: the add-on groups had higher CD4 (mean difference 4.98), CD8 and natural killer cell levels, less bone-marrow suppression (myelosuppression; risk ratio 0.38) and less radiation pneumonitis (lung inflammation from radiotherapy; risk ratio 0.74), with no difference in liver and kidney damage or gastrointestinal reactions. Every trial tested Cordyceps alongside standard treatment, not on its own.
- Kidney inflammation — consistent with the traditional "kidney tonic" use, Cordyceps has been studied as an adjunct in chronic kidney disease (Cochrane review, 2014), with the review flagging generally low trial quality. That review of Cordyceps sinensis pooled 22 studies with 1746 participants. In people with chronic kidney disease not on dialysis, Cordyceps preparations lowered serum creatinine (mean difference −60.76 μmol/L, 14 studies, 987 participants) and raised creatinine clearance (mean difference 9.22 mL/min), both markers of kidney filtering. Risk of bias was judged high in four studies and unclear in 18, and “definitive conclusions could not be made because of the low quality of evidence.”
The pattern is consistent across all of these: promising mechanism, encouraging animal data, thin or preliminary human evidence.
Autoimmune Disease and Immunosuppressants
This is the single most important safety point on the page. Because Cordyceps can stimulate immune activity, the research raises a theoretical concern for two groups:
- People with autoimmune diseases (rheumatoid arthritis, lupus, multiple sclerosis, psoriasis, inflammatory bowel disease, autoimmune thyroid disease). In these conditions the immune system is already over-active against the body's own tissue; theoretically, stimulating it further could aggravate disease. The anti-inflammatory cordycepin arm complicates the prediction, and the net effect in autoimmune disease is unknown.
- People taking immunosuppressant medication — transplant recipients on drugs such as tacrolimus, cyclosporine, or mycophenolate, and patients on biologics or other immune-suppressing therapy. Cordyceps could theoretically counteract the intended immunosuppression, and there are also possible pharmacokinetic interactions.
See our pages on Rheumatology and Immunology for the conditions involved.
Practical Use
- Form: products differ; some report their beta-glucan content. The human immune trials used a Paecilomyces hepiali mycelium extract and C. militaris preparations, and C. militaris supplies more cordycepin. Some products carry third-party testing of their contents.
- Dose: the human immune trials used 1.68 g/day (Jung 2019) and 1.5 g/day (Kang 2015) of extract, and a 2024 trial used a drink containing 2.85 mg of cordycepin; there is no official immune dose.
- Expectations: the trials measured modest immune-marker changes over 4 to 8 weeks, not fewer illnesses. It is not a treatment for any infection.
- Who the concerns apply to: the theoretical concerns centre on surgery, autoimmune conditions and immune-related medication (see Cautions below).
- Other immune factors: sleep, nutrition, and vitamin D, zinc and vitamin C status are covered on their own pages.
Cautions
- Autoimmune disease / immunosuppressants: the key caution above — a theoretical concern of extra immune stimulation and drug interactions.
- Bleeding risk: possible mild anti-platelet effect; the theoretical concern is extra bleeding with anticoagulants and during surgery.
- Blood sugar: possible additive lowering with diabetes medication, so blood sugar could fall further than the medicine alone would take it.
- Pregnancy and breastfeeding: there are no adequate pregnancy or breastfeeding safety data.
- Allergy and quality: mushroom/mold-allergic people may react; wild O. sinensis is costly, frequently adulterated, and can carry heavy metals; cultivated material is also sold.
Key Research Papers
- Jung SJ, et al. (2019). Immunomodulatory effects of a mycelium extract of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial. BMC Complement Altern Med — PubMed PMID: 30925876
- Kang HJ, et al. (2015). Cordyceps militaris enhances cell-mediated immunity in healthy Korean men. J Med Food — PubMed PMID: 26284906
- Kim HG, et al. (2006). Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-κB. Eur J Pharmacol — PubMed PMID: 16899239
- Choi YH, Kim GY, Lee HH (2014). Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways. Drug Des Devel Ther — PubMed PMID: 25342887
- Tan L, et al. (2020). Anti-inflammatory effects of cordycepin: a review. Phytother Res — PubMed PMID: 33090621
- Liu Y, et al. (2024). Immunomodulatory effect of Cordyceps militaris polysaccharide on RAW 264.7 macrophages by regulating MAPK signaling pathways. Molecules — PubMed PMID: 39064986
- Chen L, et al. (2024). Cordyceps polysaccharides: a review of their immunomodulatory effects. Molecules — PubMed PMID: 39519748
- Das G, et al. (2020). Cordyceps spp.: a review on its immune-stimulatory and other biological potentials. Front Pharmacol — PubMed PMID: 33628175
- Zhang Y, et al. (2020). Structural characterization, antioxidant and immunomodulatory activities of a neutral polysaccharide from Cordyceps militaris cultivated on hull-less barley. Carbohydr Polym — PubMed PMID: 32122503
- Ontawong A, et al. (2024). A randomized controlled clinical trial examining the effects of Cordyceps militaris beverage on the immune response in healthy adults. Sci Rep — PubMed PMID: 38580687
- Zhang HW, Lin ZX, Tung YS, Kwan TH, Mok CK, Leung C, Chan LS (2014). Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev — PubMed PMID: 25519252
- Wang C, Wang J, Qi Y (2024). Adjuvant treatment with Cordyceps sinensis for lung cancer: a systematic review and meta-analysis of randomized controlled trials. J Ethnopharmacol — PubMed PMID: 38484953
PubMed Topic Searches
Connections
- Cordyceps Mushroom (Main Page)
- Cordyceps Benefits Hub
- Cordyceps for Respiratory Support
- Cordyceps, Cordycepin & Adenosine Triphosphate
- Immune Boosting
- Turkey Tail Mushroom
- Reishi Mushroom
- Chaga Mushroom
- Astragalus
- Vitamin D3
- Vitamin C
- Zinc
- Immunology
- Rheumatology
- Anti-Inflammatory Diet
- All Mushrooms